Tenaya Therapeutics
Price & Volume
Stats
See more52W Range | $0.36-$3.69 |
Market Cap | $234.7M |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.75 |
News
See moreYahoo Finance • last month
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
Yahoo Finance • last month
Tenaya Therapeutics falls after FDA clinical hold on heart disorder trial
Yahoo Finance • last month
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
Yahoo Finance • 2 months ago
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
About
CEO | Mr. Faraz Ali M.B.A. |
Address | 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 97 |
